The IAS COVID-19 Conference: Prevention

Advances in vaccine technologies and trials are leading to robust data for global vaccination efforts. Current vaccines have varying degrees of efficacy, and emerging variants are creating further deviation, suggesting a need for a rapid increase in vaccinations as well as improved molecular surveillance.

Kenneth Mayer, MD Released: March 18, 2021

Data demonstrate potential for monoclonal antibodies in treatment and prevention of COVID-19 in select patients. Emergence of variants may affect current and future utility and will necessitate discernment from healthcare professionals.

Renslow Sherer, MD Released: March 9, 2021